D.E. Shaw & Co’s Harvard Bioscience HBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-85,569
| Closed | -$237K | – | 3415 |
|
|
2022
Q4 | $237K | Sell |
85,569
-154
| -0.2% | -$427 | ﹤0.01% | 2974 |
|
|
2022
Q3 | $220K | Buy |
85,723
+45,034
| +111% | +$116K | ﹤0.01% | 3185 |
|
|
2022
Q2 | $146K | Buy |
+40,689
| New | +$146K | ﹤0.01% | 3482 |
|
|
2017
Q3 | – | Sell |
-29,528
| Closed | -$75K | – | 2528 |
|
|
2017
Q2 | $75K | Sell |
29,528
-46,317
| -61% | -$118K | ﹤0.01% | 2340 |
|
|
2017
Q1 | $197K | Sell |
75,845
-1,338
| -2% | -$3.48K | ﹤0.01% | 2286 |
|
|
2016
Q4 | $235K | Buy |
77,183
+1,229
| +2% | +$3.74K | ﹤0.01% | 2301 |
|
|
2016
Q3 | $207K | Buy |
75,954
+6,511
| +9% | +$17.7K | ﹤0.01% | 2317 |
|
|
2016
Q2 | $199K | Buy |
69,443
+5,060
| +8% | +$14.5K | ﹤0.01% | 2385 |
|
|
2016
Q1 | $194K | Buy |
64,383
+8,974
| +16% | +$27K | ﹤0.01% | 2397 |
|
|
2015
Q4 | $192K | Buy |
55,409
+41,585
| +301% | +$144K | ﹤0.01% | 2440 |
|
|
2015
Q3 | $52K | Sell |
13,824
-5,394
| -28% | -$20.3K | ﹤0.01% | 2496 |
|
|
2015
Q2 | $110K | Sell |
19,218
-13,828
| -42% | -$79.1K | ﹤0.01% | 2541 |
|
|
2015
Q1 | $192K | Buy |
33,046
+22,842
| +224% | +$133K | ﹤0.01% | 2379 |
|
|
2014
Q4 | $58K | Buy |
+10,204
| New | +$58K | ﹤0.01% | 2432 |
|
|
2013
Q3 | – | Sell |
-14,090
| Closed | -$67K | – | 2462 |
|
|
2013
Q2 | $67K | Buy |
+14,090
| New | +$67K | ﹤0.01% | 2294 |
|